{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:46:32Z","timestamp":1793303192615,"version":"4.5.0"},"reference-count":159,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T00:00:00Z","timestamp":1755388800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["T34GM137854"],"award-info":[{"award-number":["T34GM137854"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP210180 \/ RP230419 \/ RP250567"],"award-info":[{"award-number":["RP210180 \/ RP230419 \/ RP250567"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020374","name":"Government of India Ministry of Ayush","doi-asserted-by":"publisher","award":["ANRF\/IRG\/2024\/000620\/LS"],"award-info":[{"award-number":["ANRF\/IRG\/2024\/000620\/LS"]}],"id":[{"id":"10.13039\/100020374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54MD019970 \/ GM139727"],"award-info":[{"award-number":["U54MD019970 \/ GM139727"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioactive Materials"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bioactmat.2025.08.016","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T20:47:27Z","timestamp":1756327647000},"page":"423-449","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Nanotechnology strategies for endometrium health: Are we on the right track?"],"prefix":"10.1016","volume":"54","author":[{"given":"Victoria","family":"Herrara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Tarab-Ravski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhash C.","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikesh","family":"Narang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Mirazul Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Peer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajendra","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0073-8828","authenticated-orcid":false,"given":"Murali M.","family":"Yallapu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bioactmat.2025.08.016_bib1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/modpathol.3880050","article-title":"Hormonal pathology of the endometrium","volume":"13","author":"Deligdisch","year":"2000","journal-title":"Mod. Pathol."},{"issue":"3","key":"10.1016\/j.bioactmat.2025.08.016_bib2","first-page":"1149","article-title":"Physiology of the endometrium and regulation of menstruation","volume":"100","author":"Critchley","year":"2020"},{"issue":"12","key":"10.1016\/j.bioactmat.2025.08.016_bib3","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1007\/s00261-016-0930-5","article-title":"Through thick and thin: a pictorial review of the endometrium","volume":"41","author":"Caserta","year":"2016","journal-title":"Abdominal Radiology"},{"issue":"6","key":"10.1016\/j.bioactmat.2025.08.016_bib4","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/biolre\/ioae073","article-title":"Targeted nanoparticles for imaging and therapy of endometriosis","volume":"110","author":"Slayden","year":"2024","journal-title":"Biol. Reprod."},{"issue":"5","key":"10.1016\/j.bioactmat.2025.08.016_bib5","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1017\/S0967199423000424","article-title":"Therapeutic potential of nanotechnology in reproduction disorders and possible limitations","volume":"31","author":"Barroso","year":"2023","journal-title":"Zygote"},{"issue":"42","key":"10.1016\/j.bioactmat.2025.08.016_bib6","doi-asserted-by":"crossref","first-page":"8755","DOI":"10.2174\/0929867328666210705144456","article-title":"Endometrial cancer: genetic, metabolic characteristics, therapeutic strategies and nanomedicine","volume":"28","author":"Cai","year":"2021","journal-title":"Curr. Med. Chem."},{"issue":"14","key":"10.1016\/j.bioactmat.2025.08.016_bib7","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.2217\/nnm-2023-0346","article-title":"Rethinking the application of nanoparticles in women's reproductive health and assisted reproduction","volume":"19","author":"Davis","year":"2024","journal-title":"Nanomedicine (London, England)"},{"issue":"9","key":"10.1016\/j.bioactmat.2025.08.016_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/molecules29092095","article-title":"The role of nanomedicine in benign gynecologic disorders","volume":"29","author":"Lulseged","year":"2024","journal-title":"Molecules"},{"issue":"41","key":"10.1016\/j.bioactmat.2025.08.016_bib9","article-title":"The application of nanoparticle-based imaging and phototherapy for female reproductive organs diseases","volume":"20","author":"Luo","year":"2024","journal-title":"Small"},{"issue":"3","key":"10.1016\/j.bioactmat.2025.08.016_bib10","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1021\/acsabm.3c01064","article-title":"Recent advances in nanotechnology-based drug delivery systems for the diagnosis and treatment of reproductive disorders","volume":"7","author":"Acharya","year":"2024","journal-title":"ACS Appl. Bio Mater."},{"issue":"4","key":"10.1016\/j.bioactmat.2025.08.016_bib11","first-page":"313","article-title":"In situ photo responsive biodegradable nanoparticle forming intrauterine implant for drug delivery to treat ovarian diseases: a rationale-based review","volume":"17","author":"Corrie","year":"2024","journal-title":"Curr. Rad."},{"issue":"2","key":"10.1016\/j.bioactmat.2025.08.016_bib12","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/humupd\/dmaa049","article-title":"Nanoparticles in pregnancy: the next frontier in reproductive therapeutics","volume":"27","author":"Pritchard","year":"2021","journal-title":"Hum. Reprod. Update"},{"issue":"9","key":"10.1016\/j.bioactmat.2025.08.016_bib13","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1248\/yakushi.131.1271","article-title":"[drug discovery by formulation design and innovative drug delivery systems (DDS)]","volume":"131","author":"Okada","year":"2011","journal-title":"Yakugaku Zasshi : J. Pharm. Soc. Jpn."},{"issue":"11","key":"10.1016\/j.bioactmat.2025.08.016_bib14","first-page":"1866","article-title":"A comprehensive review of advanced diagnostic techniques for endometriosis: new approaches to improving women's well-being","volume":"60","author":"Kaspute","year":"2024"},{"issue":"7","key":"10.1016\/j.bioactmat.2025.08.016_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202004975","article-title":"Nanomedicines for endometriosis: lessons learned from cancer research","volume":"17","author":"Moses","year":"2021","journal-title":"Small"},{"issue":"6","key":"10.1016\/j.bioactmat.2025.08.016_bib16","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s13346-017-0423-2","article-title":"Drug delivery for the treatment of endometriosis and uterine fibroids","volume":"7","author":"Friend","year":"2017","journal-title":"Drug delivery and translational research"},{"issue":"1","key":"10.1016\/j.bioactmat.2025.08.016_bib17","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s12943-024-02163-z","article-title":"Folate-engineered chitosan nanoparticles: next-generation anticancer nanocarriers","volume":"23","author":"Kesharwani","year":"2024","journal-title":"Mol. Cancer"},{"issue":"6","key":"10.1016\/j.bioactmat.2025.08.016_bib18","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s12015-024-10739-x","article-title":"Placenta-targeted treatment strategies for preeclampsia and fetal growth restriction: an opportunity and major challenge","volume":"20","author":"Cui","year":"2024","journal-title":"Stem cell reviews and reports"},{"issue":"41","key":"10.1016\/j.bioactmat.2025.08.016_bib19","article-title":"Particles and prejudice: Nanomedicine approaches to reducing health disparities in endometrial cancer","volume":"20","author":"Rowlands","year":"2024","journal-title":"Small"},{"issue":"3","key":"10.1016\/j.bioactmat.2025.08.016_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10030679","article-title":"Benefit of silver and gold nanoparticles in wound healing process after endometrial cancer protocol","volume":"10","author":"Toczek","year":"2022","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.bioactmat.2025.08.016_bib21","first-page":"321","article-title":"Sentinel lymph node mapping in endometrial cancer after 2020 ESGO-ESTRO-ESP consensus update: what will happen in the next few years?","volume":"93","author":"Barczynski","year":"2022","journal-title":"Ginekol. Pol."},{"issue":"1","key":"10.1016\/j.bioactmat.2025.08.016_bib22","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1097\/JS9.0000000000002064","article-title":"Comparison of different tracers in sentinel lymph node detection for endometrial cancer: a systematic review and network meta-analysis","volume":"111","author":"Feng","year":"2024","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.bioactmat.2025.08.016_bib23","article-title":"Oral nano-formulations for endocrine therapy of endometrioid adenocarcinomas","volume":"179","author":"Cui","year":"2024","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"issue":"3","key":"10.1016\/j.bioactmat.2025.08.016_bib24","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1021\/acsnano.4c13513","article-title":"Voices of nanomedicine: blueprint guidelines for collaboration in addressing global unmet medical needs","volume":"19","author":"Prasad","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioactmat.2025.08.016_bib25","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/924362","article-title":"Different effects of the immunomodulatory drug GMDP immobilized onto aminopropyl modified and unmodified mesoporous silica nanoparticles upon peritoneal macrophages of women with endometriosis","volume":"2013","author":"Antsiferova","year":"2013","journal-title":"BioMed Res. Int."},{"issue":"3","key":"10.1016\/j.bioactmat.2025.08.016_bib26","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.nano.2012.08.001","article-title":"Mitigation of endometriosis using regenerative cerium oxide nanoparticles","volume":"9","author":"Chaudhury","year":"2013","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.bioactmat.2025.08.016_bib27","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.jconrel.2024.12.074","article-title":"Nanoceria as a non-steroidal anti-inflammatory drug for endometriosis theranostics","volume":"378","author":"Rahman","year":"2025","journal-title":"J. Contr. Release"},{"issue":"5","key":"10.1016\/j.bioactmat.2025.08.016_bib28","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1166\/jbn.2015.2020","article-title":"Nanoparticle-assisted combinatorial therapy for effective treatment of endometriosis","volume":"11","author":"Singh","year":"2015","journal-title":"J. Biomed. Nanotechnol."},{"issue":"4","key":"10.1016\/j.bioactmat.2025.08.016_bib29","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1080\/10837450.2017.1290107","article-title":"Development and characterization of poly(lactic-co-glycolic) acid nanoparticles loaded with copaiba oleoresin","volume":"23","author":"de Almeida Borges","year":"2018","journal-title":"Pharmaceut. Dev. Technol."},{"issue":"11","key":"10.1016\/j.bioactmat.2025.08.016_bib30","first-page":"697","article-title":"Effect of PLGA nanoparticle-mediated delivery of miRNA 503 on the apoptosis of ovarian endometriosis cells","volume":"24","author":"Chaichian","year":"2022","journal-title":"Cell journal"},{"key":"10.1016\/j.bioactmat.2025.08.016_bib31","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.actbio.2024.02.017","article-title":"Microfluidics-derived hierarchical microparticles for the delivery of dienogest for localized endometriosis therapy","volume":"178","author":"Wu","year":"2024","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bioactmat.2025.08.016_bib32","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.colsurfb.2019.04.014","article-title":"Preparation of letrozole dispersed pHEMA\/AAm-g-LDPE drug release system: in-Vitro release kinetics for the treatment of endometriosis","volume":"179","author":"Siddiqa","year":"2019","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"1","key":"10.1016\/j.bioactmat.2025.08.016_bib33","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s13287-017-0706-z","article-title":"miR-200c suppresses endometriosis by targeting MALAT1 in vitro and in vivo","volume":"8","author":"Liang","year":"2017","journal-title":"Stem Cell Res. Ther."},{"issue":"6","key":"10.1016\/j.bioactmat.2025.08.016_bib34","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1182\/blood.V52.6.1099.1099","article-title":"Low-density lipoprotein (LDL) receptor activity in human acute myelogenous leukemia cells","volume":"52","author":"Ho","year":"1978","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.bioactmat.2025.08.016_bib35","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/humrep\/dew303","article-title":"mRNA levels of low-density lipoprotein receptors are overexpressed in the foci of deep bowel endometriosis","volume":"32","author":"Gibran","year":"2017","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.bioactmat.2025.08.016_bib36","doi-asserted-by":"crossref","DOI":"10.6061\/clinics\/2019\/e989","article-title":"Nanotechnology for the treatment of deep endometriosis: uptake of lipid core nanoparticles by LDL receptors in endometriotic foci","volume":"74","author":"Bedin","year":"2019","journal-title":"Clinics"},{"issue":"2","key":"10.1016\/j.bioactmat.2025.08.016_bib37","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00404-023-07246-8","article-title":"Pilot study of treatment of patients with deep infiltrative endometriosis with methotrexate carried in lipid nanoparticles","volume":"309","author":"Avila-Tavares","year":"2024","journal-title":"Arch. Gynecol. Obstet."},{"issue":"1\u20133","key":"10.1016\/j.bioactmat.2025.08.016_bib38","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejphar.2013.01.011","article-title":"\u03b2-Caryophyllene causes regression of endometrial implants in a rat model of endometriosis without affecting fertility","volume":"702","author":"Abbas","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bioactmat.2025.08.016_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123049","article-title":"Development, characterization and evidence of anti-endometriotic activity of phytocannabinoid-rich nanoemulsions","volume":"643","author":"Nogueira Barradas","year":"2023","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.bioactmat.2025.08.016_bib40","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.biomaterials.2011.09.077","article-title":"Gene therapy of endometriosis introduced by polymeric micelles with glycolipid-like structure","volume":"33","author":"Zhao","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioactmat.2025.08.016_bib41","doi-asserted-by":"crossref","first-page":"8171","DOI":"10.2147\/IJN.S146569","article-title":"Effect of A-317491 delivered by glycolipid-like polymer micelles on endometriosis pain","volume":"12","author":"Yuan","year":"2017","journal-title":"Int. J. Nanomed."},{"issue":"21","key":"10.1016\/j.bioactmat.2025.08.016_bib42","first-page":"4927","article-title":"Lipoxin A4 suppresses the development of endometriosis in an ALX receptor-dependent manner via the p38 MAPK pathway","volume":"171","author":"Wu","year":"2014"},{"issue":"12","key":"10.1016\/j.bioactmat.2025.08.016_bib43","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1177\/1933719119828115","article-title":"Lipoxin A4 suppresses IL-1\u03b2-Induced Cyclooxygenase-2 expression through inhibition of p38 MAPk activation in endometriosis","volume":"26","author":"Dai","year":"2019","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.bioactmat.2025.08.016_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.106108","article-title":"BML-111 attenuates high glucose-induced inflammation, oxidative stress and reduces extracellular matrix accumulation via targeting Nrf2 in rat glomerular mesangial cells","volume":"79","author":"Wu","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bioactmat.2025.08.016_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2022.112893","article-title":"A multifunctional nanoparticle for efferocytosis and pro-resolving-mediated endometriosis therapy","volume":"220","author":"Sun","year":"2022","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"10","key":"10.1016\/j.bioactmat.2025.08.016_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13101618","article-title":"Cell-penetrating peptide and siRNA-Mediated therapeutic effects on endometriosis and cancer in vitro models","volume":"13","author":"Kiisholts","year":"2021","journal-title":"Pharmaceutics"},{"issue":"18","key":"10.1016\/j.bioactmat.2025.08.016_bib47","article-title":"Nanoparticle-based platform for activatable fluorescence imaging and photothermal ablation of endometriosis","volume":"16","author":"Moses","year":"2020","journal-title":"Small"},{"issue":"24","key":"10.1016\/j.bioactmat.2025.08.016_bib48","article-title":"Targeted nanoparticles with high heating efficiency for the treatment of endometriosis with systemically delivered magnetic hyperthermia","volume":"18","author":"Park","year":"2022","journal-title":"Small"},{"issue":"1","key":"10.1016\/j.bioactmat.2025.08.016_bib49","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s40824-023-00442-2","article-title":"Injectable hydrogel nanoarchitectonics with near-infrared controlled drug delivery for in situ photothermal\/endocrine synergistic endometriosis therapy","volume":"27","author":"Tian","year":"2023","journal-title":"Biomater. Res."},{"key":"10.1016\/j.bioactmat.2025.08.016_bib50","doi-asserted-by":"crossref","first-page":"2409778","DOI":"10.1002\/advs.202409778","article-title":"Injectable Magnetic Hydrogel Incorporated with Anti-Inflammatory Peptide for Efficient Magnetothermal Treatment of Endometriosis","volume":"11","author":"Liu","year":"2024","journal-title":"Advanced Science"},{"key":"10.1016\/j.bioactmat.2025.08.016_bib51","article-title":"Peritoneal immune microenvironment of endometriosis: role and therapeutic perspectives","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioactmat.2025.08.016_bib52","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ejps.2016.10.031","article-title":"Evaluation of PLGA containing anti-CTLA4 inhibited endometriosis progression by regulating CD4+CD25+Treg cells in peritoneal fluid of mouse endometriosis model","volume":"96","author":"Liu","year":"2017","journal-title":"Eur. J. Pharmaceut. Sci. : official journal of the European Federation for Pharmaceutical Sciences"},{"issue":"10","key":"10.1016\/j.bioactmat.2025.08.016_bib53","first-page":"680","article-title":"[experimental research on the treatment of mouse endometriosis model with nanoparticles loaded with CCR5-antibody]","volume":"54","author":"Zhang","year":"2019","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"10.1016\/j.bioactmat.2025.08.016_bib54","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.actbio.2024.09.037","article-title":"Targeting delivery of mifepristone to endometrial dysfunctional macrophages for endometriosis therapy","volume":"189","author":"Zhang","year":"2024","journal-title":"Acta Biomater."},{"issue":"8","key":"10.1016\/j.bioactmat.2025.08.016_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15082108","article-title":"iRGD-Targeted peptide nanoparticles for anti-angiogenic RNAi-Based therapy of endometriosis","volume":"15","author":"Egorova","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioactmat.2025.08.016_bib56","article-title":"Hyaluronic acid-modified nanoplatforms as a vector for targeted delivery of autophagy-related gene to the endometriotic lesions in mice","volume":"10","author":"Zhao","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"12","key":"10.1016\/j.bioactmat.2025.08.016_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/nano11123257","article-title":"Homing peptide-based targeting of Tenascin-C and fibronectin in endometriosis","volume":"11","author":"Sim\u00f3n-Gracia","year":"2021","journal-title":"Nanomaterials"},{"issue":"1","key":"10.1016\/j.bioactmat.2025.08.016_bib58","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1096\/fj.201902272R","article-title":"Neutrophil recruitment and function in endometriosis patients and a syngeneic murine model","volume":"34","author":"Symons","year":"2020","journal-title":"FASEB J."},{"issue":"1\u20132","key":"10.1016\/j.bioactmat.2025.08.016_bib59","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jri.2011.05.008","article-title":"Increased levels of human neutrophil peptides 1, 2, and 3 in peritoneal fluid of patients with endometriosis: association with neutrophils, T cells and IL-8","volume":"91","author":"Milewski","year":"2011","journal-title":"J. Reprod. Immunol."},{"issue":"1","key":"10.1016\/j.bioactmat.2025.08.016_bib60","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12951-023-01831-4","article-title":"Highly specific neutrophil-mediated delivery of albumin nanoparticles to ectopic lesion for endometriosis therapy","volume":"21","author":"Zhu","year":"2023","journal-title":"J. Nanobiotechnol."},{"issue":"15","key":"10.1016\/j.bioactmat.2025.08.016_bib61","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1039\/D2NA00787H","article-title":"Endometriosis-targeted MRI imaging using bevacizumab-modified nanoparticles aimed at vascular endothelial growth factor","volume":"5","author":"Zhang","year":"2023","journal-title":"Nanoscale Adv."},{"issue":"3","key":"10.1016\/j.bioactmat.2025.08.016_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/nano14030319","article-title":"Imaging of endometriotic lesions using cRGD-MN probe in a mouse model of endometriosis","volume":"14","author":"Talebloo","year":"2024","journal-title":"Nanomaterials"},{"issue":"2","key":"10.1016\/j.bioactmat.2025.08.016_bib63","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202302175","article-title":"Photoacoustic imaging endometriosis lesions with nanoparticulate polydopamine as a contrast agent","volume":"13","author":"Lv","year":"2024","journal-title":"Adv. Healthcare Mater."},{"issue":"10","key":"10.1016\/j.bioactmat.2025.08.016_bib64","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1007\/s43032-022-00980-5","article-title":"A mouse model of endometriosis with nanoparticle labeling for in vivo photoacoustic imaging","volume":"29","author":"Marquardt","year":"2022","journal-title":"Reprod. Sci."},{"issue":"10","key":"10.1016\/j.bioactmat.2025.08.016_bib65","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1373\/clinchem.2016.257691","article-title":"A nanoparticle-lectin immunoassay improves discrimination of serum CA125 from malignant and benign sources","volume":"62","author":"Gidwani","year":"2016","journal-title":"Clin. Chem."},{"issue":"3","key":"10.1016\/j.bioactmat.2025.08.016_bib66","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1373\/jalm.2018.028266","article-title":"Europium nanoparticle-based Sialyl-Tn monoclonal antibody discriminates epithelial ovarian cancer-associated CA125 from benign sources","volume":"4","author":"Gidwani","year":"2019","journal-title":"The journal of applied laboratory medicine"},{"issue":"11","key":"10.1016\/j.bioactmat.2025.08.016_bib67","doi-asserted-by":"crossref","first-page":"7620","DOI":"10.1021\/acsabm.0c00821","article-title":"Label-free electrochemical immunosensor based on one-step electrochemical deposition of AuNP-RGO nanocomposites for detection of endometriosis marker CA 125","volume":"3","author":"Sangili","year":"2020","journal-title":"ACS Appl. Bio Mater."},{"issue":"1","key":"10.1016\/j.bioactmat.2025.08.016_bib68","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1080\/21691401.2021.1926275","article-title":"Biogenesis of copper nanoparticles (Cu-NPs) using leaf extract of Allium noeanum, antioxidant and in-vitro cytotoxicity","volume":"49","author":"Chinnathambi","year":"2021","journal-title":"Artif. Cell Nanomed. Biotechnol."},{"issue":"42","key":"10.1016\/j.bioactmat.2025.08.016_bib69","doi-asserted-by":"crossref","first-page":"39822","DOI":"10.1021\/acsomega.3c06028","article-title":"Exploring the potential of thymoquinone-stabilized selenium nanoparticles: in HEC1B endometrial cancer cells revealing enhanced anticancer efficacy","volume":"8","author":"Gulbay","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.bioactmat.2025.08.016_bib70","doi-asserted-by":"crossref","first-page":"6661","DOI":"10.2147\/IJN.S329341","article-title":"Enhancing of nanocatalyst-driven chemodynaminc therapy for endometrial cancer cells through inhibition of PINK1\/Parkin-Mediated mitophagy","volume":"16","author":"Gong","year":"2021","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.bioactmat.2025.08.016_bib71","first-page":"96","article-title":"Combination of disulfiram and copper-cysteamine nanoparticles induces mitochondria damage and promotes apoptosis in endometrial cancer","volume":"36","author":"Yang","year":"2024","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.bioactmat.2025.08.016_bib72","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.2147\/IJN.S200480","article-title":"Superparamagnetic iron oxide nanoparticle-mediated expression of miR-326 inhibits human endometrial carcinoma stem cell growth","volume":"14","author":"Gao","year":"2019","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.bioactmat.2025.08.016_bib73","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41565-017-0009-7","article-title":"Synthetically lethal nanoparticles for treatment of endometrial cancer","volume":"13","author":"Ebeid","year":"2018","journal-title":"Nat. Nanotechnol."},{"issue":"2","key":"10.1016\/j.bioactmat.2025.08.016_bib74","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ygyno.2019.08.014","article-title":"MTDH\/AEG-1 downregulation using pristimerin-loaded nanoparticles inhibits Fanconi anemia proteins and increases sensitivity to platinum-based chemotherapy","volume":"155","author":"Bi","year":"2019","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.bioactmat.2025.08.016_bib75","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1080\/09205063.2021.1974149","article-title":"Fabrication of polymer-based self-assembly nanocarriers loaded with a crizotinib and gemcitabine: potential therapeutics for the treatment of endometrial cancer","author":"Yang","year":"2022","journal-title":"Journal of biomaterials science. Polymer"},{"issue":"41","key":"10.1016\/j.bioactmat.2025.08.016_bib76","article-title":"Ciprofloxacin derivative-loaded nanoparticles synergize with paclitaxel against type II human endometrial cancer","volume":"20","author":"Naguib","year":"2024","journal-title":"Small"},{"issue":"7","key":"10.1016\/j.bioactmat.2025.08.016_bib77","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1007\/s13346-021-01065-7","article-title":"The MEK 1\/2 inhibitor PD98059 exhibits synergistic anti-endometrial cancer activity with paclitaxel in vitro and enhanced tissue distribution in vivo when formulated into PAMAM-Coated PLGA-PEG nanoparticles","volume":"12","author":"Wiwatchaitawee","year":"2022","journal-title":"Drug delivery and translational research"},{"issue":"8","key":"10.1016\/j.bioactmat.2025.08.016_bib78","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202104472","article-title":"Targeting cancer metabolism plasticity with JX06 nanoparticles via inhibiting PDK1 combined with metformin for endometrial cancer patients with diabetes","volume":"9","author":"Yang","year":"2022","journal-title":"Adv. Sci."},{"issue":"2","key":"10.1016\/j.bioactmat.2025.08.016_bib79","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/15384047.2019.1672455","article-title":"Clinical and biological significance of EZH2 expression in endometrial cancer","volume":"21","author":"Roh","year":"2020","journal-title":"Cancer Biol. Ther."},{"issue":"4","key":"10.1016\/j.bioactmat.2025.08.016_bib80","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1158\/2159-8290.CD-12-0429","article-title":"First-in-humans trial of an RNA interference therapeutic targeting VEGF and KSP in cancer patients with liver involvement","volume":"3","author":"Tabernero","year":"2013","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bioactmat.2025.08.016_bib81","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.ijbiomac.2016.12.055","article-title":"Effects of tamoxifen-loaded solid lipid nanoparticles on the estrogen receptor-\u03b1 (ER-\u03b1) and vascular endothelial growth factor-A (VEGF-A) genes expression in the endometrial tissue of ovariectomized female sprague-dawley rats","volume":"96","author":"Javid","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.bioactmat.2025.08.016_bib82","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00280-018-3702-9","article-title":"Mononuclear phagocyte system function and nanoparticle pharmacology in Obese and normal weight ovarian and endometrial cancer patients","volume":"83","author":"Starling","year":"2019","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"6","key":"10.1016\/j.bioactmat.2025.08.016_bib83","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1111\/cas.14907","article-title":"Enhanced antitumor activity of combined lipid bubble ultrasound and anticancer drugs in gynecological cervical cancers","volume":"112","author":"Yamaguchi","year":"2021","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bioactmat.2025.08.016_bib84","first-page":"3787","article-title":"Nanoemulsion liquid preconcentrates for raloxifene hydrochloride: optimization and in vivo appraisal","volume":"7","author":"Elsheikh","year":"2012","journal-title":"Int. J. Nanomed."},{"issue":"2","key":"10.1016\/j.bioactmat.2025.08.016_bib85","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4155\/tde-2022-0039","article-title":"Carboplatin-loaded ultradeformable vesicles for the management of endometrial cancer: in vitro and in vivo evaluation","volume":"14","author":"Patel","year":"2023","journal-title":"Ther. Deliv."},{"issue":"2","key":"10.1016\/j.bioactmat.2025.08.016_bib86","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1080\/10837450.2024.2307996","article-title":"Fabrication of controlled-release polymeric microneedles containing progesterone-loaded self-microemulsions for transdermal delivery","volume":"29","author":"Suriyaamporn","year":"2024","journal-title":"Pharmaceut. Dev. Technol."},{"issue":"2","key":"10.1016\/j.bioactmat.2025.08.016_bib87","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3892\/ijmm.2020.4627","article-title":"Inhibitory effects of brusatol delivered using glycosaminoglycan-placental chondroitin sulfate A-modified nanoparticles on the proliferation, migration and invasion of cancer cells","volume":"46","author":"Chen","year":"2020","journal-title":"Int. J. Mol. Med."},{"issue":"16","key":"10.1016\/j.bioactmat.2025.08.016_bib88","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13164038","article-title":"Aptamer-functionalized gold nanoparticles for drug delivery to gynecological carcinoma cells","volume":"13","author":"Lopes-Nunes","year":"2021","journal-title":"Cancers"},{"issue":"13","key":"10.1016\/j.bioactmat.2025.08.016_bib89","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1016\/j.bmc.2011.05.016","article-title":"Improved therapeutic effect of folate-decorated PLGA-PEG nanoparticles for endometrial carcinoma","volume":"19","author":"Liang","year":"2011","journal-title":"Bioorg. Med. Chem."},{"issue":"16","key":"10.1016\/j.bioactmat.2025.08.016_bib90","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13164032","article-title":"Hyaluronic acid-functionalized nanomicelles enhance SAHA efficacy in 3D endometrial cancer models","volume":"13","author":"Edwards","year":"2021","journal-title":"Cancers"},{"issue":"7","key":"10.1016\/j.bioactmat.2025.08.016_bib91","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10071680","article-title":"Novel endometrial cancer models using sensitive metastasis tracing for CXCR4-Targeted therapy in advanced disease","volume":"10","author":"Medina-Guti\u00e9rrez","year":"2022","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.bioactmat.2025.08.016_bib92","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15010085","article-title":"Potent anticancer activity of CXCR4-Targeted nanostructured toxins in aggressive endometrial cancer models","volume":"15","author":"Medina-Guti\u00e9rrez","year":"2022","journal-title":"Cancers"},{"issue":"15","key":"10.1016\/j.bioactmat.2025.08.016_bib93","doi-asserted-by":"crossref","first-page":"5812","DOI":"10.7150\/ijbs.101059","article-title":"Dual-multivalent aptamer-based drug delivery platform for targeted SRC silencing to enhance doxorubicin sensitivity in endometrial cancer","volume":"20","author":"Li","year":"2024","journal-title":"Int. J. Biol. Sci."},{"issue":"6","key":"10.1016\/j.bioactmat.2025.08.016_bib94","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.jmig.2018.11.002","article-title":"Comparison study of laparoscopic sentinel lymph node mapping in endometrial carcinoma using carbon nanoparticles and lymphatic pathway verification","volume":"26","author":"Zuo","year":"2019","journal-title":"J. Minim. Invasive Gynecol."},{"issue":"3","key":"10.1016\/j.bioactmat.2025.08.016_bib95","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/jso.26518","article-title":"Carbon nanoparticles combined with indocyanine green for sentinel lymph node detection in endometrial carcinoma","volume":"124","author":"Liang","year":"2021","journal-title":"J. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.bioactmat.2025.08.016_bib96","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/jso.27268","article-title":"Comparing carbon nanoparticles and indocyanine green for sentinel lymph node mapping in endometrial cancer: a randomized-controlled single-center trial","volume":"128","author":"He","year":"2023","journal-title":"J. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.bioactmat.2025.08.016_bib97","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1007\/s00464-023-10662-1","article-title":"Sentinel lymph node biopsy with carbon dye in endometrial cancer: a single center, prospective cohort study","volume":"38","author":"Minareci","year":"2024","journal-title":"Surg. Endosc."},{"issue":"9","key":"10.1016\/j.bioactmat.2025.08.016_bib98","first-page":"605","article-title":"[clinical analysis of 76 cases of sentinel lymph node detection in cervical cancer and endometrial cancer","volume":"52","author":"Liang","year":"2017","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"issue":"5","key":"10.1016\/j.bioactmat.2025.08.016_bib99","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1007\/s00404-023-07111-8","article-title":"Comparison of sentinel lymph node distribution and lymphatic drainage pathway between high- and low-risk endometrial cancers","volume":"308","author":"Chen","year":"2023","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.bioactmat.2025.08.016_bib100","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/6528572","article-title":"Coordination of nanoconjugation with an antigen\/antibody for efficient detection of gynecological tumors","volume":"2020","author":"Liu","year":"2020","journal-title":"Journal of analytical methods in chemistry"},{"issue":"9","key":"10.1016\/j.bioactmat.2025.08.016_bib101","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1021\/acssensors.0c00953","article-title":"Hybrid nanoplasmonic porous biomaterial scaffold for liquid biopsy diagnostics using extracellular vesicles","volume":"5","author":"Rojalin","year":"2020","journal-title":"ACS Sens."},{"issue":"22","key":"10.1016\/j.bioactmat.2025.08.016_bib102","doi-asserted-by":"crossref","first-page":"8973","DOI":"10.1021\/acs.analchem.4c00042","article-title":"Surface-enhanced raman spectroscopy-based detection of EMT-related targets in endometrial cancer: potential for diagnosis and prognostic prediction","volume":"96","author":"Ma","year":"2024","journal-title":"Anal. Chem."},{"issue":"3","key":"10.1016\/j.bioactmat.2025.08.016_bib103","first-page":"87","article-title":"Histopathological study of female beagle dogs for four year treatment with subcutaneous implantation of chlormadinone acetate (CMA)","volume":"25","author":"Murakoshi","year":"2000","journal-title":"Tokai J. Exp. Clin. Med."},{"issue":"6","key":"10.1016\/j.bioactmat.2025.08.016_bib104","doi-asserted-by":"crossref","DOI":"10.3390\/ani11061516","article-title":"Modulation of bovine endometrial cell receptors and signaling pathways as a nanotherapeutic exploration against dairy cow postpartum endometritis","volume":"11","author":"Oladejo","year":"2021","journal-title":"Animals : an open access journal from MDPI"},{"issue":"9","key":"10.1016\/j.bioactmat.2025.08.016_bib105","doi-asserted-by":"crossref","DOI":"10.3390\/polym14091848","article-title":"Infectious inflammatory processes and the role of bioactive agent released from imino-chitosan derivatives experimental and theoretical aspects","volume":"14","author":"Himiniuc","year":"2022","journal-title":"Polymers"},{"issue":"12","key":"10.1016\/j.bioactmat.2025.08.016_bib106","doi-asserted-by":"crossref","first-page":"7516","DOI":"10.1021\/acsbiomaterials.4c01729","article-title":"Thermosensitive injectable dual drug-loaded chitosan-based hydrogels for treating bacterial endometritis","volume":"10","author":"Wang","year":"2024","journal-title":"ACS biomaterials science & engineering"},{"issue":"1","key":"10.1016\/j.bioactmat.2025.08.016_bib107","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/19396368.2024.2306420","article-title":"Engineered exosome as a biological nanoplatform for drug delivery of rosmarinic acid to improve implantation in mice with induced endometritis","volume":"70","author":"Taravat","year":"2024","journal-title":"Syst. Biol. Reprod. Med."},{"issue":"3","key":"10.1016\/j.bioactmat.2025.08.016_bib108","first-page":"240","article-title":"Uterine adenomyosis: pathogenesis, diagnostics, symptomatology and treatment","volume":"84","author":"Lacheta","year":"2019","journal-title":"Cesk\u00e1 Gynekol."},{"issue":"5","key":"10.1016\/j.bioactmat.2025.08.016_bib109","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.fertnstert.2023.03.006","article-title":"Endometriosis and adenomyosis: shared pathophysiology","volume":"119","author":"Bulun","year":"2023","journal-title":"Fertil. Steril."},{"issue":"4","key":"10.1016\/j.bioactmat.2025.08.016_bib110","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.gendis.2020.01.011","article-title":"Adenomyosis-derived extracellular vesicles endow endometrial epithelial cells with an invasive phenotype through epithelial-mesenchymal transition","volume":"7","author":"Chen","year":"2020","journal-title":"Genes & diseases"},{"key":"10.1016\/j.bioactmat.2025.08.016_bib111","series-title":"Molecular Human Reproduction","article-title":"Endometrial stromal cell signaling and microRNA exosome content in women with adenomyosis","author":"Zipponi","year":"2024"},{"issue":"4","key":"10.1016\/j.bioactmat.2025.08.016_bib112","first-page":"192","article-title":"Treatment of primary and secondary dysmenorrhea with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study, the european journal of contraception & reproductive health care : the official","volume":"6","author":"Wildemeersch","year":"2001","journal-title":"journal of the European Society of Contraception"},{"issue":"9","key":"10.1016\/j.bioactmat.2025.08.016_bib113","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1093\/humrep\/den208","article-title":"Evaluation of the efficacy of a danazol-loaded intrauterine contraceptive device on adenomyosis in an ICR mouse model","volume":"23","author":"Zhang","year":"2008","journal-title":"Hum. Reprod."},{"issue":"6","key":"10.1016\/j.bioactmat.2025.08.016_bib114","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1097\/AOG.0000000000004989","article-title":"Endometrial hyperplasia","volume":"140","author":"Ring","year":"2022","journal-title":"Obstet. Gynecol."},{"issue":"7","key":"10.1016\/j.bioactmat.2025.08.016_bib115","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1007\/s10439-017-1859-8","article-title":"Engineering poly(lactic-co-glycolic acid) (PLGA) micro- and nano-carriers for controlled delivery of 17\u03b2-Estradiol","volume":"45","author":"Prakapenka","year":"2017","journal-title":"Ann. Biomed. Eng."},{"issue":"9","key":"10.1016\/j.bioactmat.2025.08.016_bib116","doi-asserted-by":"crossref","DOI":"10.3390\/nu14091891","article-title":"Piceatannol SNEDDS attenuates estradiol-induced endometrial hyperplasia in rats by modulation of NF-\u03baB and Nrf2\/HO-1 axes","volume":"14","author":"Binmahfouz","year":"2022","journal-title":"Nutrients"},{"issue":"9","key":"10.1016\/j.bioactmat.2025.08.016_bib117","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12092074","article-title":"Study on the effect of the vaginal administration of conjugated estrogens cream combined with progesterone on the endometrium of rats and its mechanism of action","volume":"12","author":"Li","year":"2024","journal-title":"Biomedicines"},{"issue":"6","key":"10.1016\/j.bioactmat.2025.08.016_bib118","first-page":"1765","article-title":"Preparation and in vitro characterization of microneedles containing inclusion complexes loaded with progesterone","volume":"15","author":"He","year":"2023"},{"issue":"2","key":"10.1016\/j.bioactmat.2025.08.016_bib119","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1055\/s-0031-1272470","article-title":"Asherman's syndrome","volume":"29","author":"March","year":"2011","journal-title":"Semin. Reprod. Med."},{"key":"10.1016\/j.bioactmat.2025.08.016_bib120","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2147\/IJWH.S165474","article-title":"Asherman's syndrome: current perspectives on diagnosis and management","volume":"11","author":"Dreisler","year":"2019","journal-title":"Int. J. Wom. Health"},{"issue":"1","key":"10.1016\/j.bioactmat.2025.08.016_bib121","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.rbmo.2010.11.018","article-title":"Management of Asherman's syndrome","volume":"23","author":"March","year":"2011","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.bioactmat.2025.08.016_bib122","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1264006","article-title":"Treatment strategies for intrauterine adhesion: focus on the exosomes and hydrogels","volume":"11","author":"Wu","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"6","key":"10.1016\/j.bioactmat.2025.08.016_bib123","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.fertnstert.2015.08.032","article-title":"Human CD133(+) bone marrow-derived stem cells promote endometrial proliferation in a murine model of asherman syndrome","volume":"104","author":"Cervell\u00f3","year":"2015","journal-title":"Fertil. Steril."},{"issue":"1","key":"10.1016\/j.bioactmat.2025.08.016_bib124","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s13287-018-0904-3","article-title":"Allogeneic cell therapy using umbilical cord MSCs on collagen scaffolds for patients with recurrent uterine adhesion: a phase I clinical trial","volume":"9","author":"Cao","year":"2018","journal-title":"Stem Cell Res. Ther."},{"issue":"1","key":"10.1016\/j.bioactmat.2025.08.016_bib125","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1186\/s13287-021-02499-z","article-title":"Unresponsive thin endometrium caused by asherman syndrome treated with umbilical cord mesenchymal stem cells on collagen scaffolds: a pilot study","volume":"12","author":"Zhang","year":"2021","journal-title":"Stem Cell Res. Ther."},{"issue":"9","key":"10.1016\/j.bioactmat.2025.08.016_bib126","first-page":"1101","article-title":"Salvage utilization of selective and super selective embolization in emergency by use of a-magnetic coil and nano-particles in gynecology","volume":"15","author":"Tinelli","year":"2011","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.bioactmat.2025.08.016_bib127","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s40265-018-0885-7","article-title":"Ferric carboxymaltose: a review in iron deficiency","volume":"78","author":"Scott","year":"2018","journal-title":"Drugs"},{"issue":"12","key":"10.1016\/j.bioactmat.2025.08.016_bib128","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1111\/j.1537-2995.2009.02327.x","article-title":"Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial","volume":"49","author":"Van Wyck","year":"2009","journal-title":"Transfusion"},{"issue":"6","key":"10.1016\/j.bioactmat.2025.08.016_bib129","first-page":"685","article-title":"Efficacy of micronised vaginal progesterone versus oral dydrogestrone in the treatment of irregular dysfunctional uterine bleeding: a pilot randomised controlled trial, the Australian & New Zealand journal of obstetrics & gynaecology","volume":"49","author":"Karakus","year":"2009"},{"issue":"1\u20133","key":"10.1016\/j.bioactmat.2025.08.016_bib130","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0168-3659(97)00132-6","article-title":"In vitro cytotoxicity and teratogenicity of norethisterone and levonorgestrel released from hollow nylon monofilaments","volume":"50","author":"Ostad","year":"1998","journal-title":"J. Contr. Release : official journal of the Controlled Release Society"},{"issue":"3","key":"10.1016\/j.bioactmat.2025.08.016_bib131","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3109\/13645706.2011.613402","article-title":"Comparative study of the intravenous chemoprophylaxix versus local sulmycin\u00ae implant E sponge use in vaginal hysterectomy, minimally invasive therapy & allied technologies : mitat","volume":"21","author":"Tsikouras","year":"2012","journal-title":"official journal of the Society for Minimally Invasive Therapy"},{"issue":"4","key":"10.1016\/j.bioactmat.2025.08.016_bib132","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jmig.2011.04.007","article-title":"Efficacy of a polyethylene oxide-sodium carboxymethylcellulose gel in prevention of intrauterine adhesions after hysteroscopic surgery","volume":"18","author":"Di Spiezio Sardo","year":"2011","journal-title":"J. Minim. Invasive Gynecol."},{"issue":"3","key":"10.1016\/j.bioactmat.2025.08.016_bib133","first-page":"138","article-title":"Comparison between direct use and PLGA nanocapsules containing drug of traditional Chinese medicine, tiaojing zhixue, in treatment of dysfunctional uterine bleeding, cellular and molecular biology (noisy-Le-grand","volume":"67","author":"Han","year":"2021","journal-title":"France)"},{"key":"10.1016\/j.bioactmat.2025.08.016_bib134","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jconrel.2019.12.007","article-title":"Therapeutic options and drug delivery strategies for the prevention of intrauterine adhesions","volume":"318","author":"Kou","year":"2020","journal-title":"J. Contr. Release"},{"issue":"6","key":"10.1016\/j.bioactmat.2025.08.016_bib135","first-page":"784","article-title":"Nano-based approved pharmaceuticals for cancer treatment: present and future challenges","volume":"12","author":"Rodr\u00edguez","year":"2022"},{"key":"10.1016\/j.bioactmat.2025.08.016_bib136","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jconrel.2014.11.027","article-title":"Monocyte-mediated delivery of polymeric backpacks to inflamed tissues: a generalized strategy to deliver drugs to treat inflammation","volume":"199","author":"Anselmo","year":"2015","journal-title":"J. Contr. Release"},{"issue":"17","key":"10.1016\/j.bioactmat.2025.08.016_bib137","article-title":"A backpack-based myeloid cell therapy for multiple sclerosis","volume":"120","author":"Kapate","year":"2023"},{"key":"10.1016\/j.bioactmat.2025.08.016_bib138","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jconrel.2024.11.037","article-title":"Backpack-carrying macrophage immunotherapy for periodontitis","volume":"377","author":"Nakajima","year":"2025","journal-title":"J. Contr. Release"},{"issue":"1","key":"10.1016\/j.bioactmat.2025.08.016_bib139","first-page":"11","article-title":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis","volume":"379","author":"Adams","year":"2018"},{"issue":"27","key":"10.1016\/j.bioactmat.2025.08.016_bib140","first-page":"2603","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020"},{"issue":"4","key":"10.1016\/j.bioactmat.2025.08.016_bib141","doi-asserted-by":"crossref","first-page":"5246","DOI":"10.1021\/acsnano.1c07237","article-title":"Nanoparticles accumulate in the female reproductive system during ovulation affecting cancer treatment and fertility","volume":"16","author":"Poley","year":"2022","journal-title":"ACS Nano"},{"issue":"3","key":"10.1016\/j.bioactmat.2025.08.016_bib142","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101314","article-title":"Protein is expressed in all major organs after intravenous infusion of mRNA-lipid nanoparticles in swine","volume":"32","author":"Ferraresso","year":"2024","journal-title":"Molecular Therapy - Methods & Clinical Development"},{"issue":"8","key":"10.1016\/j.bioactmat.2025.08.016_bib143","doi-asserted-by":"crossref","first-page":"4691","DOI":"10.1021\/jacs.2c12893","article-title":"Ionizable lipid nanoparticles for in vivo mRNA delivery to the placenta during pregnancy","volume":"145","author":"Swingle","year":"2023","journal-title":"J. Am. Chem. Soc."},{"issue":"8045","key":"10.1016\/j.bioactmat.2025.08.016_bib144","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41586-024-08291-2","article-title":"Placenta-tropic VEGF mRNA lipid nanoparticles ameliorate murine pre-eclampsia","volume":"637","author":"Swingle","year":"2025","journal-title":"Nature"},{"issue":"41","key":"10.1016\/j.bioactmat.2025.08.016_bib145","article-title":"Orthogonal design of experiments for engineering of lipid nanoparticles for mRNA delivery to the placenta","volume":"20","author":"Safford","year":"2024"},{"issue":"12","key":"10.1016\/j.bioactmat.2025.08.016_bib146","doi-asserted-by":"crossref","first-page":"4800","DOI":"10.1021\/acs.nanolett.4c06241","article-title":"Probing the role of lipid nanoparticle elasticity on mRNA delivery to the placenta","volume":"25","author":"Safford","year":"2025","journal-title":"Nano Lett."},{"key":"10.1016\/j.bioactmat.2025.08.016_bib147","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jconrel.2024.05.036","article-title":"EGFR-Targeted ionizable lipid nanoparticles enhance in vivo mRNA delivery to the placenta","volume":"371","author":"Geisler","year":"2024","journal-title":"J. Contr. Release"},{"issue":"7","key":"10.1016\/j.bioactmat.2025.08.016_bib148","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nrc1123","article-title":"Ovarian cancer: strategies for overcoming resistance to chemotherapy","volume":"3","author":"Agarwal","year":"2003","journal-title":"Nat. Rev. Cancer"},{"issue":"14","key":"10.1016\/j.bioactmat.2025.08.016_bib149","article-title":"Therapeutic gene silencing of CKAP5 leads to lethality in genetically unstable cancer cells","volume":"9","author":"Chatterjee","year":"2023"},{"issue":"47","key":"10.1016\/j.bioactmat.2025.08.016_bib150","article-title":"CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy","volume":"6","author":"Rosenblum","year":"2020"},{"issue":"9","key":"10.1016\/j.bioactmat.2025.08.016_bib151","first-page":"1","article-title":"Intrauterine device completely encapsulated by fibrous tissue in a postmenopausal woman: a case report","volume":"85","author":"Huang","year":"2024"},{"issue":"1","key":"10.1016\/j.bioactmat.2025.08.016_bib152","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s11671-023-03943-0","article-title":"Exploration of inorganic nanoparticles for revolutionary drug delivery applications: a critical review","volume":"18","author":"Unnikrishnan","year":"2023","journal-title":"Discover nano"},{"key":"10.1016\/j.bioactmat.2025.08.016_bib153","doi-asserted-by":"crossref","DOI":"10.1016\/j.matdes.2020.108805","article-title":"Review of hybrid PLGA nanoparticles: future of smart drug delivery and theranostics medicine","volume":"193","author":"Ghitman","year":"2020","journal-title":"Mater. Des."},{"issue":"8","key":"10.1016\/j.bioactmat.2025.08.016_bib154","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13081291","article-title":"Polymeric lipid hybrid nanoparticles (PLNs) as emerging drug delivery Platform-A comprehensive review of their properties, preparation methods, and therapeutic applications","volume":"13","author":"Sivadasan","year":"2021","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.bioactmat.2025.08.016_bib155","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics17060797","article-title":"Lipid-polymer hybrid nanoparticles as a smart drug delivery system for peptide\/protein delivery","volume":"17","author":"Hassan","year":"2025","journal-title":"Pharmaceutics"},{"issue":"7","key":"10.1016\/j.bioactmat.2025.08.016_bib156","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1039\/C4BM00427B","article-title":"Lipid-coated polymeric nanoparticles for cancer drug delivery","volume":"3","author":"Krishnamurthy","year":"2015","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.bioactmat.2025.08.016_bib157","author":"Awosika","year":"2025"},{"key":"10.1016\/j.bioactmat.2025.08.016_bib158","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.102017","article-title":"Bevacizumab (avastin\u00ae) in cancer treatment: a review of 15 years of clinical experience and future outlook","volume":"86","author":"Garcia","year":"2020","journal-title":"Cancer Treat Rev."},{"issue":"1","key":"10.1016\/j.bioactmat.2025.08.016_bib159","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13023-019-1012-x","article-title":"Efficacy and safety of mTOR inhibitors (rapamycin and its analogues) for Tuberous sclerosis complex: a meta-analysis","volume":"14","author":"Li","year":"2019","journal-title":"Orphanet J. Rare Dis."}],"container-title":["Bioactive Materials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X2500369X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X2500369X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:11:34Z","timestamp":1778890294000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452199X2500369X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":159,"alternative-id":["S2452199X2500369X"],"URL":"https:\/\/doi.org\/10.1016\/j.bioactmat.2025.08.016","relation":{},"ISSN":["2452-199X"],"issn-type":[{"value":"2452-199X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanotechnology strategies for endometrium health: Are we on the right track?","name":"articletitle","label":"Article Title"},{"value":"Bioactive Materials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioactmat.2025.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}